# Cumberland Pharmaceuticals Inc: filings

CPIX · Nasdaq · CIK 1087294 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cpix.md) · [Financials](/companies/cpix/financials.md) · [Filings](/companies/cpix/filings.md) · [Insiders](/companies/cpix/insiders.md)

## Reports and events: 324 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 465, 8-K 228, 10-Q 52, SC 13G/A 30, CT ORDER 27, 3 23, CORRESP 21, SC 13G 21, 10-K 17, DEF 14A 16, UPLOAD 16, 5 15, DEFA14A 9, 4/A 6, S-1/A 6, EFFECT 5, 8-K/A 4, ARS 4, S-3 4, SCHEDULE 13G 4, 3/A 3, 424B5 3, S-3/A 3, SC TO-I/A 3, S-8 2, SCHEDULE 13G/A 2, 10-Q/A 1, 424B4 1, CERTNAS 1, DEFM14A 1, DEFR14A 1, DEL AM 1, PREM14A 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 17:01 ET | [8-K](/filings/0001087294-26-000070.md) | 8.01 Other events | 0001087294-26-000070 |
| 2026-09-11 | 16:51 ET | [8-K/A](/filings/0001087294-26-000068.md) | 5.07 Shareholder vote results | 0001087294-26-000068 |
| 2026-08-28 | 17:08 ET | [8-K](/filings/0001087294-26-000064.md) | 7.01 Regulation FD disclosure | 0001087294-26-000064 |
| 2026-08-07 | 17:12 ET | [10-Q](/filings/0001087294-26-000062.md) | Quarterly report, period 2026-06-30 | 0001087294-26-000062 |
| 2026-08-04 | 17:20 ET | [8-K](/filings/0001087294-26-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001087294-26-000058 |
| 2026-07-13 | 17:28 ET | [8-K](/filings/0001087294-26-000055.md) | 8.01 Other events | 0001087294-26-000055 |
| 2026-07-01 | 16:15 ET | [8-K](/filings/0001104659-26-079871.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-079871 |
| 2026-06-25 | 17:00 ET | [8-K](/filings/0001087294-26-000053.md) | 5.07 Shareholder vote results | 0001087294-26-000053 |
| 2026-05-08 | 17:02 ET | [10-Q](/filings/0001087294-26-000049.md) | Quarterly report, period 2026-03-31 | 0001087294-26-000049 |
| 2026-05-05 | 17:07 ET | [8-K](/filings/0001087294-26-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001087294-26-000046 |
| 2026-04-24 | 17:08 ET | [8-K](/filings/0001087294-26-000043.md) | 5.07 Shareholder vote results | 0001087294-26-000043 |
| 2026-04-23 | 09:01 ET | [8-K](/filings/0001104659-26-047335.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-047335 |
| 2026-03-09 | 17:01 ET | [DEF 14A](/filings/0001087294-26-000025.md) | Proxy statement, period 2025-12-31 | 0001087294-26-000025 |
| 2026-03-09 | 20:54 ET | [10-K](/filings/0001087294-26-000020.md) | Annual report, period 2025-12-31 | 0001087294-26-000020 |
| 2026-03-03 | 17:10 ET | [8-K](/filings/0001087294-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001087294-26-000015 |
| 2026-02-04 | 17:20 ET | [8-K](/filings/0001087294-26-000011.md) | 8.01 Other events | 0001087294-26-000011 |
| 2025-11-24 | 20:26 ET | [8-K](/filings/0001087294-25-000023.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001087294-25-000023 |
| 2025-11-07 | 17:05 ET | [10-Q](/filings/0001087294-25-000020.md) | Quarterly report, period 2025-09-30 | 0001087294-25-000020 |
| 2025-11-04 | 17:11 ET | [8-K](/filings/0001087294-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001087294-25-000017 |
| 2025-10-21 | 09:25 ET | [8-K](/filings/0001087294-25-000012.md) | 8.01 Other events | 0001087294-25-000012 |
| 2025-08-08 | 17:03 ET | [10-Q](/filings/0001628280-25-039326.md) | Quarterly report, period 2025-06-30 | 0001628280-25-039326 |
| 2025-08-05 | 17:05 ET | [8-K](/filings/0001628280-25-037923.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-037923 |
| 2025-05-09 | 17:01 ET | [10-Q](/filings/0001628280-25-024342.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024342 |
| 2025-05-06 | 17:02 ET | [8-K](/filings/0001628280-25-022753.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022753 |
| 2025-04-28 | 15:38 ET | [8-K](/filings/0001628280-25-020222.md) | 5.07 Shareholder vote results | 0001628280-25-020222 |
| 2025-03-19 | 17:07 ET | [8-K](/filings/0001628280-25-013875.md) | 8.01 Other events | 0001628280-25-013875 |
| 2025-03-10 | 17:00 ET | [DEF 14A](/filings/0001628280-25-011735.md) | Proxy statement, period 2024-12-31 | 0001628280-25-011735 |
| 2025-03-07 | 17:15 ET | [10-K](/filings/0001628280-25-011366.md) | Annual report, period 2024-12-31 | 0001628280-25-011366 |
| 2025-03-04 | 17:09 ET | [8-K](/filings/0001628280-25-009967.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-009967 |
| 2025-02-19 | 17:00 ET | [8-K](/filings/0001628280-25-006430.md) | 8.01 Other events | 0001628280-25-006430 |
| 2025-02-14 | 16:25 ET | [8-K](/filings/0001628280-25-005744.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-005744 |
| 2025-02-04 | 16:37 ET | [8-K](/filings/0001628280-25-003753.md) | 8.01 Other events | 0001628280-25-003753 |
| 2024-12-09 | 17:04 ET | [8-K](/filings/0001628280-24-050499.md) | 8.01 Other events | 0001628280-24-050499 |
| 2024-11-12 | 06:55 ET | [8-K](/filings/0001628280-24-046827.md) | 8.01 Other events | 0001628280-24-046827 |
| 2024-11-08 | 17:04 ET | [10-Q](/filings/0001628280-24-046730.md) | Quarterly report, period 2024-09-30 | 0001628280-24-046730 |
| 2024-11-07 | 17:09 ET | [8-K](/filings/0001628280-24-046399.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-046399 |
| 2024-11-06 | 17:12 ET | [8-K](/filings/0001628280-24-045807.md) | 8.01 Other events | 0001628280-24-045807 |
| 2024-11-04 | 17:15 ET | [8-K](/filings/0001628280-24-045054.md) | 8.01 Other events | 0001628280-24-045054 |
| 2024-08-09 | 17:03 ET | [10-Q](/filings/0001628280-24-036529.md) | Quarterly report, period 2024-06-30 | 0001628280-24-036529 |
| 2024-08-06 | 17:07 ET | [8-K](/filings/0001628280-24-035262.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035262 |
| 2024-05-10 | 16:37 ET | [10-Q](/filings/0001628280-24-022658.md) | Quarterly report, period 2024-03-31 | 0001628280-24-022658 |
| 2024-05-07 | 17:14 ET | [8-K](/filings/0001628280-24-021185.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021185 |
| 2024-04-29 | 16:53 ET | [8-K](/filings/0001628280-24-019053.md) | 5.07 Shareholder vote results | 0001628280-24-019053 |
| 2024-03-20 | 17:20 ET | [8-K](/filings/0001628280-24-012261.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-012261 |
| 2024-03-13 | 17:03 ET | [DEF 14A](/filings/0001628280-24-010960.md) | Proxy statement, period 2023-12-31 | 0001628280-24-010960 |
| 2024-03-13 | 21:14 ET | [10-K](/filings/0001628280-24-010725.md) | Annual report, period 2023-12-31 | 0001628280-24-010725 |
| 2024-03-05 | 17:10 ET | [8-K](/filings/0001628280-24-009006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-009006 |
| 2023-11-13 | 08:15 ET | [10-Q](/filings/0001628280-23-038418.md) | Quarterly report, period 2023-09-30 | 0001628280-23-038418 |
| 2023-11-07 | 17:21 ET | [8-K](/filings/0001628280-23-037446.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037446 |
| 2023-10-13 | 09:11 ET | [8-K](/filings/0001628280-23-034316.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-034316 |

Page 1 of 7. [Older](/companies/cpix/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:41 ET. No prices; not investment advice.